Research shows that the damage from high blood pressure often happens slowly over many years. A study published in the New ...

The drug came to AstraZeneca through its acquisition of CinCor Pharma in 2023, with the hopes of beefing up its ...

AstraZeneca's new drug, baxdrostat, has successfully lowered blood pressure in a late-stage trial for treatment-resistant ...

Understanding the link between obesity, fatty liver disease and kidney stones provides a new perspective on prevention and ...

Baxdrostat, which AstraZeneca acquired in a 2023 buyout of CinCor Pharma, could become a new treatment for people whose hypertension is either uncontrolled by or resistant to existing medicines.

Certain medications can affect your body's ability to tolerate hot weather. Diuretics, beta-blockers, and some antipsychotics ...

One in three adults in the U.S. has three or more risk factors for a newly recognized but increasingly common condition: ...

Chronic kidney disease (CKD) and hypertension are common health problems among childhood cancer survivors with potentially life-threatening sequelae.

High doses of NSAIDs can be harmful to your kidneys, according to he National Kidney Foundation. The Foundation’s website ...